TY - JOUR
AU - P. M. Hughes
AU - C. W. Easterly
AU - K. C. Thomas
AU - C. M. Shea
AU - M. E. Domino
A1 - 
AD - From the Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC (PMH, KCT); Division of Research, UNC Health Sciences at MAHEC, Asheville, NC (PMH); Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC (PMH, KCT); MD/PhD Program, UNC School of Medicine, Chapel Hill, NC (CWE); Department of Health Policy and Management, Gillings School of Global Public Health, UNC Chapel Hill (CWE, CMS); and Center for Health Information and Research, College of Health Solutions, Arizona State University, Phoenix, AZ (MED).
AN - 38345239
BT - J Addict Med
C5 - Opioids & Substance Use; Education & Workforce; Financing & Sustainability; Healthcare Disparities; Healthcare Policy
CP - 2
DA - Mar-Apr 01
DO - 10.1097/adm.0000000000001272
DP - NLM
ET - 20240209
IS - 2
JF - J Addict Med
LA - eng
PY - 2024
SN - 1932-0620 (Print); 1932-0620
SP - e1
EP - e7+
ST - North Carolina Medicaid System Perspectives on Substance Use Disorder Treatment Policy Changes During the COVID-19 Pandemic
T1 - North Carolina Medicaid System Perspectives on Substance Use Disorder Treatment Policy Changes During the COVID-19 Pandemic
T2 - J Addict Med
TI - North Carolina Medicaid System Perspectives on Substance Use Disorder Treatment Policy Changes During the COVID-19 Pandemic
U1 - Opioids & Substance Use; Education & Workforce; Financing & Sustainability; Healthcare Disparities; Healthcare Policy
U3 - 10.1097/adm.0000000000001272
VL - 18
VO - 1932-0620 (Print); 1932-0620
Y1 - 2024
ER -